PATENT CLAIM ANALYSIS

Application Number: 15758595
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["514", "729000"]

Abstract:
The present invention relates to sobrerol or a pharmaceutically acceptable salt thereof, which can promote differentiation of myoblasts to form myotubes, thereby preventing muscle weakness and effectively improving muscle functions. Therefore, the pharmaceutical composition containing the same can be effectively used for preventing or treating muscle weakness related diseases.

Claim (Index 24):
The method of  claim 22 , which increases the level of mRNA of a myogenic regulatory factor or a protein expressed by the mRNA.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 90.0
- Lexical Diversity: 1.28571
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15374225', '14783426', '15891278', '12679866', '15241523']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7557445496183102
- 35 USC 102 Novelty (BERT): 0.5378738988830574
- Combined Prediction Score: 0.7339574845447849
- Mean Citation Score: 271.38906000000003
- Max Citation Score: 372.6024
- Similarity Product: 198.15969558649056

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test